Assessing Viatris (VTRS) Valuation After A Recent Share Price Pullback

Simply Wall St.04-11

Viatris (VTRS) is back on many investors’ screens after its recent share price pullback, with the stock closing at US$13.47 and showing mixed performance over the past month and the past 3 months. See...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2626124646?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2026-04-11 23:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626124646","market":"sg","top_or_hot":-1,"title":"Assessing Viatris (VTRS) Valuation After A Recent Share Price Pullback","media":"Simply Wall St.","content":"<div>\n<p>Viatris (VTRS) is back on many investors’ screens after its recent share price pullback, with the stock closing at US$13.47 and showing mixed performance over the past month and the past 3 months. See...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/assessing-viatris-vtrs-valuation-after-a-recent-share-price\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Viatris (VTRS) Valuation After A Recent Share Price Pullback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Viatris (VTRS) Valuation After A Recent Share Price Pullback\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-11 23:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/assessing-viatris-vtrs-valuation-after-a-recent-share-price><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Viatris (VTRS) is back on many investors’ screens after its recent share price pullback, with the stock closing at US$13.47 and showing mixed performance over the past month and the past 3 months. See...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/assessing-viatris-vtrs-valuation-after-a-recent-share-price\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/assessing-viatris-vtrs-valuation-after-a-recent-share-price","article_id":"2626124646","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/assessing-viatris-vtrs-valuation-after-a-recent-share-price","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2626124646","pubTimestamp":1775920605,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Viatris (VTRS) is back on many investors’ screens after its recent share price pullback, with the stock closing at US$13.47 and showing mixed performance over the past month and the past 3 months.\nSee our latest analysis for Viatris.\nThat pullback sits against a stronger backdrop, with an 8.11% year to date share price return and a 1 year total shareholder return of 86.97%. This suggests that recent momentum has softened after a strong run.\nIf Viatris has you thinking about where else value...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","BK4588":"碎股","BK4585":"ETF&股票定投概念","VTRS":"Viatris Inc.","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","BK4007":"制药"},"translate_title":"在最近股价回调后评估Viatris(VTRS)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTRS":1.5},"content_text":"Viatris (VTRS) is back on many investors’ screens after its recent share price pullback, with the stock closing at US$13.47 and showing mixed performance over the past month and the past 3 months. See our latest analysis for Viatris. That pullback sits against a stronger backdrop, with an 8.11% year to date share price return and a 1 year total shareholder return of 86.97%. This suggests that recent momentum has softened after a strong run. If Viatris has you thinking about where else value might be hiding in the market, it could be worth scanning for companies through our 18 top founder-led companies So with Viatris showing a recent pullback against strong 1 year and 3 year returns, is the current price hinting at undervaluation, or are markets already factoring in whatever growth may lie ahead? AdvertisementMost Popular Narrative: 65.7% Undervalued According to a widely followed narrative from user Adje1959, Viatris' fair value of $39.24 sits well above the recent $13.47 share price, which is presented as a sizeable discount.  Today, Viatris stands in a very different position than its stock price suggests. The company is described as extremely undervalued, trading at a forward P/E around 5, offering a solid dividend, and finally showing signs of a sustained recovery. If the transformation continues, with growth in new products, further debt reduction, and a market rerating, the bull scenario price target is presented as between $16 and $18, reflecting meaningful upside from current levels.  Read the complete narrative. Curious what underpins a fair value almost three times the current price? The narrative leans heavily on earnings power, margin resilience, and a re rated profit multiple. The full story connects these moving parts into one clear valuation case. Result: Fair Value of $39.24 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you still need to weigh risks such as ongoing net losses of US$3,514.9m, as well as the possibility that competitive pressure limits any future rerating in the shares. Find out about the key risks to this Viatris narrative. Next Steps With sentiment split between a strong past return and sizeable risks, it makes sense to check the numbers yourself and decide quickly where you stand by weighing the 3 key rewards and 1 important warning sign Looking for more investment ideas? If Viatris is on your radar, do not stop here. Broaden your watchlist with a few focused stock lists that can surface opportunities you might otherwise miss.  Target potential upside by scanning companies our models flag as attractively priced through the 58 high quality undervalued stocks. Strengthen your income focus by reviewing businesses that feature in the 11 dividend fortresses. Prioritise resilience by checking companies highlighted in the 72 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626124646","isCrawlerRequest":true}